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Vulvar cancer is an uncommon disease, accounting for 3–5% of all
gynecological malignancies. In the Netherlands the incidence rate is
approximately 1–2/100,000 women. Only 15% of the invasive vulvar
cancer occurs in women younger than 50 year (De Hullu & Van der
Zee, 2006). Cancer complicates approximately 1 in 1000–2000 preg-
nancies and mainly breast cancer and haematologic malignancies
are diagnosed (Van Calsteren et al., 2010). Cancer types diagnosed
during pregnancy reﬂect the young age group and vulvar cancer during
pregnancy is a rare co-incidence. The use of sentinel lymph node biopsy
is a standard procedure in early vulvar cancer but has not been reported
yet during pregnancy.
Case
A 27-year-old Caucasian woman, 19 weeks pregnant of a dichorial,
diamniotic twin pregnancy, presented with a painful vulvar mass
which already existed some months before her conception. She is a
non-smoker and had no relevant medical history. She never had sur-
gery. Her social economic class is mediocre, she completed middle-
level applied education in administration and now she works as a
salesperson.
The physical examination revealed a 12 mm verrucous, ulcerative
lesion on the right labiumminus. Also some lichen sclerosis was seen,
with fusion of the labia, caudal of the clitoris. The distance between⁎ Corresponding author at: Scharenhulsedijk 7, 9321XR Peize, The Netherlands.
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differentiated squamous cell carcinoma (SCC) with an invasion
depth of 1.4 mm. There was no sign of vascular invasion or perineural
growth. Human papillomavirus (HPV) was not detected.
After consultation and discussion with the oncology work group, a
local excision of the carcinoma was performed with sparing of the
groins and clitoris. Histopathology demonstrated a well-differentiated
SCC with a horizontal spread of 13 mm and an invasion depth of
2.1 mm. Resection surfaces were free and there was no sign of vascular
invasion or perineural growth. Because of the inﬁltration depth in the
local excision, unilateral sentinel node procedure (SNP) was indicated.
99mTc was used for sentinel node identiﬁcation, in dosages of 10.73 and
10.15 and 11.07 and 9.9 MBq on 4 sites of injection. The scintigraphy is
presented in Fig. 1. Because of the pregnancy, patent blue has not been
used in this procedure. The unilateral sentinel node was negative for
lymphatic disease.
The patient was staged as vulvar carcinoma FIGO stage Ib, grade I
and no adjuvant treatment was planned. Caesarean section was per-
formed for obstetrical reason at a gestational age of 38 weeks and
three days. Both infants were born healthy.
According to the national guidelines on follow up, no follow up
imaging was done. One year later she still had no sign of relapse.
Discussion
We describe the ﬁrst case of sentinel lymph node biopsy for vulvar
cancer during pregnancy. Invasive vulvar cancer is rare in young
women, especially in pregnant women. The patient in this case did
not have any of the known risk factors for vulvar cancer.
In the absence of randomised trials or large studies, there is no
standard treatment for vulvar cancer during pregnancy. Based on ex-
pert opinion, invasive vulvar cancer with clinical negative lymph
nodes during pregnancy should preferably be treated as in non-pregnant
women (Amant et al., 2009). Adequatematernalmonitoringwithmain-
tenance of maternal homeostasis is the best guarantee for fetal well
being. Pregnancy can increase blood loss during surgery. This is due to
the hypervascularization of the pelvis. Therefore effective haemostasis
is important. In addition, safemargins are important since adjuvant vul-
var radiotherapy is detrimental for the fetus. Especiallywhen there is no
uterinemanipulation, there is no proven beneﬁt of prophylactic tocoly-
sis (Amant et al., 2009). Vulvar scarring is a relative indication for cae-
sarean section. Results of previous research in breast cancer during
pregnancy show that SNP with 99mTc can be performed safely during
pregnancy. Also in cervical cancer, the most common gynecological ma-
lignancy during pregnancy, the use of SNL is assumed safe (Silva et al., license.
Fig. 1. Scintigraphy for the detection of inguinal sentinel nodes in a pregnant patient
with vulvar cancer.
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tention, however. Therefore, precise calculation of fetal exposure to ra-
diation with nuclear physicists is mandatory. It is estimated that 80% of
the dosage remains in the pelvis and the distance from the fetus is at
least 10 cm. With a theoretical dosage of 100 MBq 99mTc, the fetal riskis negligible, because the fetal exposure is 1000 times lower than the
lowest dosage with fetal risk. In this case a dosage of 41.85 MBq 99mTc
has been used, which is assumed safe for the fetus. Anaphylactic
shock reaction to patent blue has been described. This condition is po-
tentially life-threatening for mother and fetus and the use of patent
blue is therefore not recommended during pregnancy (Amant et al.,
2009). Although the SNP appears safe for the fetus, maternal follow
up is mandatory to document oncological safety. More cases and their
outcome can be registered in an international database (www.
cancerinpregnancy.org).
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